|
|
Article: Hormone therapy debate continues post WHI: the effects of postmenopausal HT on both heart disease risk and breast cancer risk remain unclear.(Women's Health)
- Article from:
- Internal Medicine News
- Article date:
- November 1, 2006
- Author:
CopyrightCOPYRIGHT 2006 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LA JOLLA, CALIF. -- It's time to rekindle enthusiasm for postmenopausal hormone therapy, Dr. Leon Speroff said at the annual meeting of the Association of Reproductive Health Professionals.
"In my view, postmenopausal hormone therapy is in a stalled position and it's time to move forward," Dr. Speroff, professor of obstetrics and gynecology and reproductive endocrinology at Oregon Health and Science University, Portland, said in an interview.
"The initial negative impact of the Women's Health Initiative is over, we know the study's limitations, we know that some of the conclusions promoted in the media were not correct, and we know that the risks that ...